P330 Inflammatory Bowel Disease (IBD) patients frequently report adverse drug reactions during biologic therapy: A multicentre, prospective, patient-reported pharmacovigilance monitoring system

Pepijn W. A. Thomas, Frank Hoentjen, M. Russel et al.|Journal of Crohn s and Colitis|2020

Cited by 3